FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

68293009: Methenamine mandelate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
113441013 Methenamine mandelate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
808112013 Methenamine mandelate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2579446011 Hexamine mandelate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
824551000172118 mandélate de méthénamine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Methenamine mandelate Is a Product containing methenamine (medicinal product) false Inferred relationship Some
Methenamine mandelate Is a Methenamine (substance) false Inferred relationship Some
Methenamine mandelate Is a Hexamine false Inferred relationship Some
Methenamine mandelate Is a Methenamine (substance) false Inferred relationship Some
Methenamine mandelate Is a Antibacterial true Inferred relationship Some
Methenamine mandelate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Methenamine (substance) true Inferred relationship Some
Methenamine mandelate Is a Rubber compound true Inferred relationship Some
Methenamine mandelate Is a Cosmetic series patch test substance true Inferred relationship Some
Methenamine mandelate Is a Amine and/or amine derivative true Inferred relationship Some
Methenamine mandelate Is a Epoxy series patch test substance true Inferred relationship Some
Methenamine mandelate Is a allergène médicamenteux false Inferred relationship Some
Methenamine mandelate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Methenamine mandelate 100 mg/mL oral suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methenamine mandelate Inferred relationship Some
Methenamine mandelate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methenamine mandelate Inferred relationship Some
Product containing precisely methenamine mandelate 1 gram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methenamine mandelate Inferred relationship Some
Product containing methenamine mandelate 0.5 gram/1 each oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methenamine mandelate Inferred relationship Some
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methenamine mandelate Inferred relationship Some
Product containing only methenamine mandelate 500 mg and sodium acid phosphate 500 mg/1 each oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methenamine mandelate Inferred relationship Some
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methenamine mandelate Inferred relationship Some
Product containing methenamine mandelate and sodium phosphate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methenamine mandelate Inferred relationship Some
Methenamine mandelate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methenamine mandelate Inferred relationship Some 1
Methenamine mandelate 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Methenamine mandelate Inferred relationship Some 1
Product containing precisely methenamine mandelate 1 gram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methenamine mandelate Inferred relationship Some 1
Product containing precisely methenamine mandelate 1 gram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Methenamine mandelate Inferred relationship Some 1
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Methenamine mandelate Inferred relationship Some 1
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Methenamine mandelate Inferred relationship Some 1
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methenamine mandelate Inferred relationship Some 2
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Methenamine mandelate Inferred relationship Some 2
Product containing only methenamine mandelate 500 mg and sodium acid phosphate 500 mg/1 each oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methenamine mandelate Inferred relationship Some 2
Product containing only methenamine mandelate 500 mg and sodium acid phosphate 500 mg/1 each oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Methenamine mandelate Inferred relationship Some 2
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methenamine mandelate Inferred relationship Some 2
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Methenamine mandelate Inferred relationship Some 2
Methenamine mandelate 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Methenamine mandelate Inferred relationship Some 1
Product containing precisely methenamine mandelate 1 gram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Methenamine mandelate Inferred relationship Some 1
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Methenamine mandelate Inferred relationship Some 1
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Methenamine mandelate Inferred relationship Some 1
Methenamine mandelate 100 mg/mL oral suspension The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Methenamine mandelate Inferred relationship Some 1
Methenamine mandelate 100 mg/mL oral suspension This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Methenamine mandelate Inferred relationship Some 1
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Methenamine mandelate Inferred relationship Some 2
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Methenamine mandelate Inferred relationship Some 2

This concept is not in any reference sets

Back to Start